Acuta Capital Partners’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-669,158
| Closed | -$897K | – | 39 |
|
|
2022
Q4 | $897K | Hold |
669,158
| – | – | 0.55% | 28 |
|
|
2022
Q3 | $1.32M | Buy |
669,158
+24,009
| +4% | +$47.3K | 0.57% | 31 |
|
|
2022
Q2 | $1.54M | Buy |
645,149
+445,149
| +223% | +$1.06M | 0.86% | 30 |
|
|
2022
Q1 | $808K | Sell |
200,000
-477,753
| -70% | -$1.93M | 0.38% | 33 |
|
|
2021
Q4 | $7.44M | Buy |
+677,753
| New | +$7.44M | 3.13% | 10 |
|